InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
InfuSystem Holdings (NYSE American: INFU) announced it will release its preliminary fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025, before market opening. The company will host an investor conference call at 9:00 a.m. Eastern Time on the same day to discuss the results.
Interested parties can participate in the call by dialing (833) 366-1127 or (412) 902-6773, or listen via a live webcast available in the Investors section of the company's website. A replay will be accessible for 90 days on the company's website or by calling (877) 344-7529 or (412) 317-0088 with replay access code 9301008 through March 11, 2025.
InfuSystem is a national healthcare service provider operating under a two-platform model: Patient Services (offering last-mile solutions for clinic-to-home healthcare) and Device Solutions (supporting Patient Services with direct payer rentals, pump and consumable sales, and biomedical services).
InfuSystem Holdings (NYSE American: INFU) ha annunciato che rilascerà i suoi risultati finanziari preliminari per il quarto trimestre e l'intero anno 2024 martedì 4 marzo 2025, prima dell'apertura del mercato. L'azienda ospiterà una call con gli investitori alle 9:00 ora orientale dello stesso giorno per discutere i risultati.
Le parti interessate possono partecipare alla chiamata componendo il numero (833) 366-1127 o (412) 902-6773, oppure ascoltare tramite una diretta streaming disponibile nella sezione Investitori del sito web dell'azienda. Una registrazione sarà accessibile per 90 giorni sul sito web dell'azienda o chiamando (877) 344-7529 o (412) 317-0088 con il codice di accesso alla registrazione 9301008 fino all'11 marzo 2025.
InfuSystem è un fornitore nazionale di servizi sanitari che opera secondo un modello a due piattaforme: Servizi per i Pazienti (che offre soluzioni per la salute dal clinico al domicilio) e Soluzioni per Dispositivi (che supportano i Servizi per i Pazienti con affitti diretti ai pagatori, vendite di pompe e consumabili, e servizi biomedici).
InfuSystem Holdings (NYSE American: INFU) anunció que publicará sus resultados financieros preliminares del cuarto trimestre y del año completo 2024 el martes 4 de marzo de 2025, antes de la apertura del mercado. La empresa llevará a cabo una llamada de conferencia para inversores a las 9:00 a.m. hora del Este el mismo día para discutir los resultados.
Las partes interesadas pueden participar en la llamada marcando (833) 366-1127 o (412) 902-6773, o escuchar a través de una transmisión en vivo disponible en la sección de Inversores del sitio web de la empresa. Una repetición estará accesible durante 90 días en el sitio web de la empresa o llamando al (877) 344-7529 o (412) 317-0088 con el código de acceso a la repetición 9301008 hasta el 11 de marzo de 2025.
InfuSystem es un proveedor nacional de servicios de salud que opera bajo un modelo de dos plataformas: Servicios para Pacientes (ofreciendo soluciones de atención médica de última milla desde la clínica hasta el hogar) y Soluciones de Dispositivos (apoyando los Servicios para Pacientes con alquileres directos a pagadores, ventas de bombas y consumibles, y servicios biomédicos).
InfuSystem Holdings (NYSE American: INFU)는 2025년 3월 4일 화요일, 시장 개장 전에 2024년 4분기 및 연간 재무 결과에 대한 예비 발표를 할 것이라고 발표했습니다. 회사는 같은 날 오전 9시(동부 표준시)에 투자자 컨퍼런스 콜을 개최하여 결과를 논의할 예정입니다.
관심 있는 분들은 (833) 366-1127 또는 (412) 902-6773로 전화하거나 회사 웹사이트의 투자자 섹션에서 제공되는 라이브 웹캐스트를 통해 참여할 수 있습니다. 재생은 회사 웹사이트에서 90일 동안 접근 가능하며, (877) 344-7529 또는 (412) 317-0088로 전화하여 재생 접근 코드 9301008을 입력하면 2025년 3월 11일까지 이용할 수 있습니다.
InfuSystem은 두 가지 플랫폼 모델로 운영되는 국가 의료 서비스 제공업체입니다: 환자 서비스(클리닉에서 가정으로의 마지막 단계 솔루션 제공) 및 장치 솔루션(환자 서비스를 지원하는 직접 지불자 임대, 펌프 및 소모품 판매, 생물 의학 서비스 제공).
InfuSystem Holdings (NYSE American: INFU) a annoncé qu'elle publiera ses résultats financiers préliminaires du quatrième trimestre et de l'année entière 2024 le mardi 4 mars 2025, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique pour les investisseurs le même jour à 9h00, heure de l'Est, pour discuter des résultats.
Les parties intéressées peuvent participer à l'appel en composant le (833) 366-1127 ou le (412) 902-6773, ou écouter via un webinaire en direct disponible dans la section Investisseurs du site web de l'entreprise. Un enregistrement sera accessible pendant 90 jours sur le site web de l'entreprise ou en appelant le (877) 344-7529 ou le (412) 317-0088 avec le code d'accès à l'enregistrement 9301008 jusqu'au 11 mars 2025.
InfuSystem est un fournisseur national de services de santé qui opère selon un modèle à deux plateformes : Services aux Patients (offrant des solutions de santé de dernier kilomètre de la clinique à la maison) et Solutions de Dispositifs (soutenant les Services aux Patients avec des locations directes aux payeurs, des ventes de pompes et de consommables, et des services biomédicaux).
InfuSystem Holdings (NYSE American: INFU) gab bekannt, dass es seine vorläufigen Finanzzahlen für das vierte Quartal und das gesamte Jahr 2024 am Dienstag, den 4. März 2025, vor Markteröffnung veröffentlichen wird. Das Unternehmen wird am selben Tag um 9:00 Uhr Eastern Time eine Investorentelefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Interessierte Parteien können an dem Anruf teilnehmen, indem sie (833) 366-1127 oder (412) 902-6773 wählen oder über ein Live-Webcast, das im Investorenbereich der Unternehmenswebsite verfügbar ist, zuhören. Eine Wiederholung wird 90 Tage lang auf der Unternehmenswebsite oder unter (877) 344-7529 oder (412) 317-0088 mit dem Wiederholungszugangscode 9301008 bis zum 11. März 2025 verfügbar sein.
InfuSystem ist ein nationaler Anbieter von Gesundheitsdienstleistungen, der unter einem Zwei-Plattform-Modell arbeitet: Patientenservices (Angebot von Lösungen für die letzte Meile der klinik-zu-Haus-Gesundheitsversorgung) und Geräteservices (Unterstützung der Patientenservices mit direkten Mietverträgen, Pumpen- und Verbraucherverkäufen sowie biomedizinischen Dienstleistungen).
- None.
- None.
Investor Conference Call to be held 9:00 a.m. Eastern Time
The Company will also conduct a conference call for all interested parties on Tuesday, March 4, 2025 at 9:00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ for the next 90 days or by calling (877) 344-7529 or (412) 317-0088, replay access code 9301008 through Tuesday, March 11, 2025.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing last-mile solutions for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225407639/en/
Joe Dorame, Joe Diaz & Robert Blum
Lytham Partners, LLC
602-889-9700
Source: InfuSystem Holdings, Inc.
FAQ
When will InfuSystem (INFU) release its Q4 and full year 2024 financial results?
How can investors participate in INFU's Q4 2024 earnings call?
What are InfuSystem's (INFU) main business segments?
Where is InfuSystem (INFU) headquartered and where does it operate?
How long will the replay of INFU's Q4 2024 earnings call be available?
